NCT07516886Recruiting
Prognostic Value of Early Postoperative Prostate-Specific Antigen for Oncological Outcomes After Radical Prostatectomy
Source: ClinicalTrials.gov · Last updated 8 Apr 2026
Brief summary (registry, in English)
This prospective observational study aims to evaluate the prognostic significance of early postoperative prostate-specific antigen (PSA) levels in patients undergoing radical prostatectomy for prostate cancer. No investigational interventions will be performed. All diagnostic procedures, follow-up assessments, and treatments will be conducted in accordance with standard clinical practice and established prostate cancer management guidelines. Participation in the study will not influence treatment decisions.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 500 (estimated)
- First submitted
- 1 Apr 2026
- Start date
- 22 Jan 2024
- Primary completion date
- Jul 2039
- Lead sponsor
- Lithuanian University of Health Sciences
- Diseases
- Prostate cancer
- NCT number
- NCT07516886
What you commit to
- Study type: Observational
- Planned participants: 500
- From 22 Jan 2024 to the primary completion date, Jul 2039
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patient received neoadjuvant prostate cancer treatment.
Other illness
- Patient has radiologically of morphologically confirmed prostate cancer metastases before the operation.
Other
- Patient is set to receive adjuvant treatment.
- Patient has any contraindications for the operation.
Who the study is looking for
- Patient is an adult biological male.
- Patient has morphologically confirmed and untreated prostate cancer.
- Patient who will be treated with open, laparoscopic or robot-assisted laparoscopic radical prostatectomy.
- Patient is informed about this observational study and has signed the informed consent form.
Age in the registry: 18 years to - · Sex: Male · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Lithuanian University of Health Sciences Hospital Kaunas Clinics, Department of Urology Coordinator of this site? Confirm its status | Kaunas | Lithuania | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.